InvestorsHub Logo

TheDane

08/03/16 9:34 AM

#156102 RE: DaubersUP #156101

Great news!

TheHound

08/03/16 9:35 AM

#156103 RE: DaubersUP #156101

“Our near-term focus is now on preparing for a Phase 2a trial of Kevetrin in treating late-stage ovarian cancer, which we anticipate will start in the fourth quarter this year,” said Cellceutix President and Chief Medical Officer Dr. Arthur P. Bertolino. “This will be a small trial that will move quickly with the end goal to provide the critical data necessary to forge a partnership with a large pharmaceutical company interested in co-developing Kevetrin as it makes progress toward possibly becoming the first p53-activating drug approved by the FDA.”

MXAMDUD

08/03/16 9:38 AM

#156106 RE: DaubersUP #156101

more fluff. watch the stock fall

frrol

08/03/16 11:12 AM

#156152 RE: DaubersUP #156101

The oral formulation would be huge, if it's possible. K clearly needs more than weekly dosing, and oral also allows for fewer clinical visits and vastly cheaper administration. They must try for a pill or subcutaneous implant. Also, the really short (2 hour) half life could be a huge impediment to therapeutic dosing, making a better delivery an imperative. Hopefully it is the sole reason we didn't see more consistent therapeutic response in the Phase 1.

Very pleased to see K moving, and in a clear direction!

CallMeCrazy

08/03/16 12:16 PM

#156157 RE: DaubersUP #156101

There's a lot to like here, but I think my personal favorite is one small-quick trial and, LET THE BIDDING BEGIN!

“This will be a small trial that will move quickly with the end goal to provide the critical data necessary to forge a partnership with a large pharmaceutical company interested in co-developing Kevetrin as it makes progress toward possibly becoming the first p53-activating drug approved by the FDA.”

DaubersUP

08/05/16 7:47 AM

#156260 RE: DaubersUP #156101

Is the phase 2a a combo trial for K? I thought it was? Anyone have a better memory than I?

Pepperchino

08/08/16 1:01 PM

#156358 RE: DaubersUP #156101

Oral formulation...$$$

Echo20

08/08/16 3:47 PM

#156377 RE: DaubersUP #156101

Daubers UP

Great post.

The dose and Dose times can be increased as the tests go on.

With K out of the body quickly it could be more valuable in regimens with other drugs.

Echo20

Echo20

08/08/16 4:03 PM

#156382 RE: DaubersUP #156101

DaubersUP

It is now needed to find how long P53 is activated by 2 hours of K in the body. Then those parameters.

Echo20